Brief: AcelRx Pharmaceuticals Q3 net income from cont ops USD -1.418 million
08/11/2023 22:57
Nov 8 (Reuters) - AcelRx Pharmaceuticals Q3 income from operations USD -3.309 million. * Q3 net income USD -1.357 million * Q3 pretax profit USD -1.416 million * Q3 net income from cont ops USD -1.418 million
Recent news on Talphera
See all newsTalphera Inc reports results for the quarter ended June 30 - Earnings Summary
Talphera Inc expected to post a loss of 7 cents a share - Earnings Preview
Talphera Q1 net loss narrows as costs rise on higher development spending
Talphera Q4 net loss widens as operating expenses rise
Brief: Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial